Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus

NCT04697485 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Enrollment and funding challenges

Conditions

HF - Heart Failure
Diabetes Mellitus

Interventions

DRUG: Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg

Sponsor

Northwestern University